Linde Q3 2026 Adjusted EPS Hits Record as Sales Rise 9%
Linde plc reported record third-quarter 2026 adjusted diluted earnings per share of $4.59, a 9% year-over-year increase, driven by pricing and higher volumes across industrial gas operations. Total sales rose 9% to $9.40 billion. The company issued full-year adjusted EPS guidance of $17.82 to $17.92, assuming no economic improvement. Key volume growth was led by Electronics, Manufacturing, and Chemicals & Energy. Linde maintained a robust project backlog of $10.8 billion and returned $4.8 billion to shareholders year to date. Key risks involve macroeconomic uncertainty, trade developments, inflation, and currency fluctuations.
Linde plc (Nasdaq: LIN) reported record adjusted diluted earnings per share of $4.59 for the third quarter of 2026, up 9% from a year earlier, as pricing and higher volumes supported growth across its industrial gas operations. The company also set full-year adjusted EPS guidance of $17.82 to $17.92, representing annual growth of 8% to 9%, with the midpoint assuming no economic improvement.
Third-quarter sales increased 9% year over year and 1% sequentially to $9.40 billion. Organic drivers included a 2% contribution from volume and 3% from price and mix, while currency, cost pass-through, acquisitions and divestitures, and Engineering each added one percentage point to annual sales growth.
Adjusted operating profit rose 8% to $2.76 billion, while adjusted net income increased 7% to $2.12 billion. The adjusted operating margin was 29.4%, compared with 29.7% a year earlier and 29.5% in the second quarter. Excluding cost pass-through, the consolidated weighted operating margin declined four basis points year over year. After-tax return on capital was 23.5%, down 110 basis points from the prior-year quarter.
Operating cash flow increased 8% year over year to $3.17 billion. Capital expenditure totaled $1.39 billion, including $750 million for projects of more than $5 million backed by long-term customer supply agreements. Available operating cash flow, defined as operating cash flow less base capital expenditure, was $2.53 billion.
Industrial end markets lead volume growth
Linde said year-over-year volume gains were driven by Electronics, Manufacturing, and Chemicals & Energy. On a comparable basis excluding currency, cost pass-through, portfolio changes and non-recurring items, Electronics sales rose 15%, Chemicals & Energy increased 12%, and Manufacturing advanced 7%. Healthcare grew 2%, Food & Beverage gained 3%, and Metals & Mining increased 3%.
The Americas remained the largest regional contributor, with sales rising 11% to $3.60 billion and adjusted operating profit increasing 12% to $1.26 billion. Its adjusted operating margin improved to 35.1% from 34.6%, supported by pricing and productivity, partly offset by cost inflation. Volume growth came from Electronics, Metals & Mining, and Chemicals & Energy, while the Mexican peso and Brazilian real provided currency tailwinds.
Asia Pacific sales increased 12% to $1.95 billion, while adjusted operating profit rose 9% to $534 million. Volume growth reflected project start-ups and equipment sales, and pricing benefited from the base business and helium. Excluding cost pass-through, the region’s year-over-year margin declined 40 basis points because of equipment sales and helium dislocation costs.
In EMEA, sales rose 7% to $2.33 billion and adjusted operating profit increased 5% to $817 million. Higher volumes were primarily associated with Healthcare and Food & Beverage, while the company continued pricing and productivity initiatives. The year-over-year margin was flat when cost pass-through was excluded.
Engineering sales increased 12% year over year to $582 million, although they declined 7% sequentially. Adjusted operating profit rose 6% to $107 million. Third-party order intake was $499 million, and the sale-of-plant backlog stood at $2.94 billion. Global Other sales increased 2% to $944 million, but adjusted operating profit fell 32% to $42 million, which Linde attributed to Lincare’s performance.
Backlog and capital allocation
Linde reported a project backlog of $10.8 billion, comprising $7.9 billion of sale-of-gas investments supported by long-term supply agreements and $2.9 billion of third-party sale-of-plant work. The company characterized the backlog as contractual growth with secure cash flows and double-digit internal rates of return.
Year to date, Linde invested $4.6 billion in the business, 10% more than in the comparable period. That included $2.0 billion of base capital expenditure and $2.6 billion of secured-growth spending, which consists of project capital expenditure and acquisitions. The company also returned $4.8 billion to shareholders through $2.6 billion of net share repurchases and $2.2 billion of dividends, while saying it maintained a strong balance sheet.
Guidance assumes no economic improvement
For the fourth quarter, Linde expects adjusted EPS of $4.40 to $4.50, up 5% to 7% year over year. The company estimates no year-over-year currency impact and a 1% sequential currency headwind. Full-year adjusted EPS is expected to be between $17.82 and $17.92, including an estimated 2% currency tailwind. Capital expenditure is projected at $5.5 billion to $6.0 billion for 2026.
Both the fourth-quarter and full-year guidance midpoints assume no economic improvement. Linde identified risks including economic and trade developments, tariffs, currency and interest-rate changes, energy and raw-material costs, the ability to offset inflation through pricing, customer and industry performance, regulatory changes, cybersecurity incidents, and execution on acquisitions and new projects.
This article may include AI-generated content that is human-reviewed, which is for reference and general information purposes only and does not constitute investment advice.
Recommended Articles











Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.